Literature DB >> 2373953

Nonuniform radiolabeling of VLDL apolipoprotein B: implications for the analysis of studies of the kinetics of the metabolism of lipoproteins containing apolipoprotein B.

R Ramakrishnan1, Y Arad, S Wong, H N Ginsberg.   

Abstract

Radiolabeling of whole lipoproteins or individual apolipoproteins has been an essential tool for the determination of the kinetics of apolipoprotein metabolism in vivo. Mathematical analysis of specific radioactivity (SA) or total radioactivity data has demonstrated the existence of significant complexity in the plasma decay curves of several apolipoproteins. Results obtained during development of methods to study the metabolism of apolipoprotein B (apoB) in very low density lipoprotein (VLDL) subclasses isolated according to flotation (Sf) rates from whole radiolabeled (d less than 1.006 g/ml) VLDL suggested nonuniform radiolabeling of apoB in the three Sf subclasses being studied. We therefore determined apoB SA in VLDL Sf subclasses in ten hypertriglyceridemic and five normal subjects. After radioiodination of apoB in whole VLDL, different apoB SA were found in Sf 400-100, Sf 100-60, and Sf 60-20. The pattern of labeling was quite variable among subjects. On average, apoB SA in the VLDL tracer was greatest in Sf 400-100, and least in Sf 60-20. Nonuniform labeling could also be demonstrated in five studies in which samples were obtained 3 min after intravenous injection of the tracer into subjects with a wide range of plasma triglycerides. Nonuniform labeling of apoB in whole VLDL was also demonstrated in two of the subjects by isolating subclasses of their VLDL that did not bind to an anti-apolipoprotein E immunoaffinity column. These results indicate that the usual assumption of homogeneous labeling of apoB may be erroneous. We have derived a simple mathematical formula to study the consequences of this assumption in estimating kinetic parameters. It is shown that an erroneous assumption of homogeneous tracer labeling may significantly underestimate or overestimate the true production rate, even in a simple two-pool model. Identification of labeling characteristics and incorporation of this information into the mathematical analysis of the plasma radioactivity data can improve the accuracy of the analysis as well as the sensitivity of compartmental models generated by such data.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2373953      PMCID: PMC3275143     

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  29 in total

1.  A Proof of the Occupancy Principle and the Mean-Transit-Time Theorem for Compartmental Models.

Authors:  Rajasekhar Ramakrishnan; Edward F Leonard; Ralph B Dell
Journal:  Math Biosci       Date:  1984-02-01       Impact factor: 2.144

2.  Catabolism of very low density lipoprotein B apoprotein in man.

Authors:  M F Reardon; N H Fidge; P J Nestel
Journal:  J Clin Invest       Date:  1978-03       Impact factor: 14.808

3.  A change in apolipoprotein B expression is required for the binding of apolipoprotein E to very low density lipoprotein.

Authors:  Y Ishikawa; C J Fielding; P E Fielding
Journal:  J Biol Chem       Date:  1988-02-25       Impact factor: 5.157

4.  Very low density lipoprotein overproduction in genetic forms of hypertriglyceridaemia.

Authors:  A Chait; J J Albers; J D Brunzell
Journal:  Eur J Clin Invest       Date:  1980-02       Impact factor: 4.686

5.  Roles of apolipoproteins B and E in the cellular binding of very low density lipoproteins.

Authors:  E S Krul; M J Tikkanen; T G Cole; J M Davie; G Schonfeld
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

6.  Overproduction of a kinetic subclass of VLDL-apoB, and direct catabolism of VLDL-apoB in human endogenous hypertriglyceridemia: an analytical model solution of tracer data.

Authors:  R P Eaton; R C Allen; D S Schade
Journal:  J Lipid Res       Date:  1983-10       Impact factor: 5.922

7.  Dissociation of apoprotein B and triglyceride production in very-low-density lipoproteins.

Authors:  J Melish; N A Le; H Ginsberg; D Steinberg; W V Brown
Journal:  Am J Physiol       Date:  1980-11

8.  Quantitative studies of very low density lipoprotein: conversion to low density lipoprotein in normal controls and primary hyperlipidaemic states and the role of direct secretion of low density lipoprotein in heterozygous familial hypercholesterolaemia.

Authors:  E D Janus; A Nicoll; R Wootton; P R Turner; P J Magill; B Lewis
Journal:  Eur J Clin Invest       Date:  1980-04       Impact factor: 4.686

9.  Metabolism of apolipoprotein B in large triglyceride-rich very low density lipoproteins of normal and hypertriglyceridemic subjects.

Authors:  C J Packard; A Munro; A R Lorimer; A M Gotto; J Shepherd
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

10.  The metabolism of apolipoprotein B in subjects with hypertriglyceridemia and polydisperse LDL.

Authors:  W R Fisher; L A Zech; P Bardalaye; G Warmke; M Berman
Journal:  J Lipid Res       Date:  1980-08       Impact factor: 5.922

View more
  7 in total

1.  Lipoprotein (a) metabolism estimated by nonsteady-state kinetics.

Authors:  K G Parhofer; T Demant; M M Ritter; H C Geiss; M Donner; P Schwandt
Journal:  Lipids       Date:  1999-04       Impact factor: 1.880

2.  Chylomicronemia due to apolipoprotein CIII overexpression in apolipoprotein E-null mice. Apolipoprotein CIII-induced hypertriglyceridemia is not mediated by effects on apolipoprotein E.

Authors:  T Ebara; R Ramakrishnan; G Steiner; N S Shachter
Journal:  J Clin Invest       Date:  1997-06-01       Impact factor: 14.808

3.  Glycated low density lipoprotein catabolism is increased in rabbits with alloxan-induced diabetes mellitus.

Authors:  W Kortlandt; C Benschop; H J van Rijn; D W Erkelens
Journal:  Diabetologia       Date:  1992-03       Impact factor: 10.122

4.  Delayed catabolism of apoB-48 lipoproteins due to decreased heparan sulfate proteoglycan production in diabetic mice.

Authors:  T Ebara; K Conde; Y Kako; Y Liu; Y Xu; R Ramakrishnan; I J Goldberg; N S Shachter
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

5.  Effect of pravastatin on metabolic parameters of apolipoprotein B in patients with mixed hyperlipoproteinemia.

Authors:  K G Parhofer; P H Barrett; J Dunn; G Schonfeld
Journal:  Clin Investig       Date:  1993-11

6.  Increased hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in NIDDM.

Authors:  M H Cummings; G F Watts; A M Umpleby; T R Hennessy; R Naoumova; B M Slavin; G R Thompson; P H Sönksen
Journal:  Diabetologia       Date:  1995-08       Impact factor: 10.122

7.  Lipoprotein kinetics in the metabolic syndrome: pathophysiological and therapeutic lessons from stable isotope studies.

Authors:  Dick C Chan; P Hugh R Barrett; Gerald F Watts
Journal:  Clin Biochem Rev       Date:  2004-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.